PrinterPrezz, a CA-based Medifacturing company, completed $16m Series A funding.
The round was led by D. One Vision Management with participation from Boutique Venture Partners, Berkeley Catalyst Fund while Solvay Ventures served as strategic investor.
Led by Shri Shetty, CEO, PrinterPrezz combines additive manufacturing technology platforms, nanotechnologies and surgical expertise to develop next generation medical devices from concept and design through FDA approval and volume production.
Committed to ongoing compliance with ISO13485:2016 and all relevant regulatory requirements including 21CFR211 and 21CFR820, the company provides customers with access to a variety of 3D printing machines, 3D manipulation software, and 3D scanners as well as advanced manufacturing processes, and surgeon education programs.
PrinterPrezz has headquarters in California, U.S. with a subsidiary in Singapore.